The Pathologist: Has Tumor Profiling Caught Up to Cancer?

Posted on

[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.0.82″ background_layout=”light” border_style=”solid” box_shadow_position=”outer”]

“I see ddPCR as the future of personalized cancer therapies. Based on our cancer center’s successful experience with the technology, I believe it is only a matter of time before these kinds of blood-based liquid biopsies become an indispensable method for doctors to categorize a patient’s disease and determine the best course of treatment.” – Dr. Scott Skibo Read the full story. 

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]